Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Buy
60
COO Quote, Financials, Valuation and Earnings
Last price:
$92.35
Seasonality move
:
10.49%
Day range:
$91.70 - $92.81
52-week range:
$84.76 - $112.38
Dividend yield:
0%
P/E ratio:
47.35x
P/S ratio:
4.75x
P/B ratio:
2.28x
Volume:
670.1K
Avg. volume:
1.5M
1-year change:
-2.8%
Market cap:
$18.4B
Revenue:
$3.9B
EPS (TTM):
$1.95
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$1B | $1.00 | 5.02% | 122.62% | $112.01 |
|
GMED
Globus Medical
|
$604.8M | $0.65 | 3.07% | 577.27% | $94.23 |
|
KIDS
OrthoPediatrics
|
$53.7M | -$0.19 | 34.88% | -11.49% | $40.17 |
|
LUCY
Innovative Eyewear
|
$900K | -$1.36 | 62.4% | -78.2% | -- |
|
NXGL
NexGel
|
$2.8M | -$0.14 | 195.01% | -20% | -- |
|
STAA
Staar Surgical
|
$86.9M | $0.17 | 2.4% | -49.22% | $41.89 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$92.34 | $112.01 | $18.4B | 47.35x | $0.01 | 0% | 4.75x |
|
GMED
Globus Medical
|
$83.56 | $94.23 | $11.4B | 124.72x | $0.00 | 0% | 4.62x |
|
KIDS
OrthoPediatrics
|
$22.89 | $40.17 | $554.3M | -- | $0.00 | 0% | 2.77x |
|
LUCY
Innovative Eyewear
|
$5.02 | -- | $12.3M | -- | $0.00 | 0% | 3.27x |
|
NXGL
NexGel
|
$4.70 | -- | $31.9M | -- | $0.00 | 0% | 4.28x |
|
STAA
Staar Surgical
|
$24.21 | $41.89 | $1.2B | 55.02x | $0.00 | 0% | 3.51x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COO
The Cooper Companies
|
24.2% | 1.416 | 12.35% | 0.81x |
|
GMED
Globus Medical
|
9.7% | 2.476 | 4.5% | 1.57x |
|
KIDS
OrthoPediatrics
|
16.38% | 0.435 | 11.07% | 3.43x |
|
LUCY
Innovative Eyewear
|
-- | 9.717 | -- | 14.63x |
|
NXGL
NexGel
|
18.36% | 1.704 | 5.91% | 0.64x |
|
STAA
Staar Surgical
|
-- | 0.076 | -- | 5.18x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$677.7M | $198.4M | 3.75% | 5.02% | 19.21% | $128.1M |
|
GMED
Globus Medical
|
$355.2M | $49M | 2.05% | 2.27% | 7.83% | $161.7M |
|
KIDS
OrthoPediatrics
|
$40.1M | -$5.6M | -7.23% | -7.63% | -16% | -$11.7M |
|
LUCY
Innovative Eyewear
|
$59.3K | -$1.8M | -113.55% | -113.55% | -678.5% | -$1.5M |
|
NXGL
NexGel
|
$1.3M | -$788K | -59.05% | -67.5% | -24.97% | -$1.2M |
|
STAA
Staar Surgical
|
$68.5M | $5.7M | 5.46% | 5.46% | 6.41% | -$2.4M |
The Cooper Companies vs. Competitors
-
Which has Higher Returns COO or GMED?
Globus Medical has a net margin of 11.54% compared to The Cooper Companies's net margin of 8.28%. The Cooper Companies's return on equity of 5.02% beat Globus Medical's return on equity of 2.27%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B GMEDGlobus Medical56.77% $0.38 $4.5B -
What do Analysts Say About COO or GMED?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 21.3%. On the other hand Globus Medical has an analysts' consensus of $94.23 which suggests that it could grow by 12.77%. Given that The Cooper Companies has higher upside potential than Globus Medical, analysts believe The Cooper Companies is more attractive than Globus Medical.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 GMEDGlobus Medical5 4 0 -
Is COO or GMED More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Globus Medical has a beta of 1.190, suggesting its more volatile than the S&P 500 by 19.035%.
-
Which is a Better Dividend Stock COO or GMED?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Globus Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Globus Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or GMED?
The Cooper Companies quarterly revenues are $1B, which are larger than Globus Medical quarterly revenues of $625.7M. The Cooper Companies's net income of $117.5M is higher than Globus Medical's net income of $51.8M. Notably, The Cooper Companies's price-to-earnings ratio is 47.35x while Globus Medical's PE ratio is 124.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.75x versus 4.62x for Globus Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.75x 47.35x $1B $117.5M GMEDGlobus Medical4.62x 124.72x $625.7M $51.8M
-
Which has Higher Returns COO or KIDS?
OrthoPediatrics has a net margin of 11.54% compared to The Cooper Companies's net margin of -14.51%. The Cooper Companies's return on equity of 5.02% beat OrthoPediatrics's return on equity of -7.63%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B KIDSOrthoPediatrics73.41% -$0.34 $443.6M -
What do Analysts Say About COO or KIDS?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 21.3%. On the other hand OrthoPediatrics has an analysts' consensus of $40.17 which suggests that it could grow by 75.48%. Given that OrthoPediatrics has higher upside potential than The Cooper Companies, analysts believe OrthoPediatrics is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 KIDSOrthoPediatrics2 1 0 -
Is COO or KIDS More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison OrthoPediatrics has a beta of 1.143, suggesting its more volatile than the S&P 500 by 14.295%.
-
Which is a Better Dividend Stock COO or KIDS?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. OrthoPediatrics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or KIDS?
The Cooper Companies quarterly revenues are $1B, which are larger than OrthoPediatrics quarterly revenues of $54.6M. The Cooper Companies's net income of $117.5M is higher than OrthoPediatrics's net income of -$7.9M. Notably, The Cooper Companies's price-to-earnings ratio is 47.35x while OrthoPediatrics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.75x versus 2.77x for OrthoPediatrics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.75x 47.35x $1B $117.5M KIDSOrthoPediatrics2.77x -- $54.6M -$7.9M
-
Which has Higher Returns COO or LUCY?
Innovative Eyewear has a net margin of 11.54% compared to The Cooper Companies's net margin of -678.5%. The Cooper Companies's return on equity of 5.02% beat Innovative Eyewear's return on equity of -113.55%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B LUCYInnovative Eyewear23.4% -$0.99 $10.9M -
What do Analysts Say About COO or LUCY?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 21.3%. On the other hand Innovative Eyewear has an analysts' consensus of -- which suggests that it could grow by 178.89%. Given that Innovative Eyewear has higher upside potential than The Cooper Companies, analysts believe Innovative Eyewear is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 LUCYInnovative Eyewear0 0 0 -
Is COO or LUCY More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Innovative Eyewear has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or LUCY?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Innovative Eyewear pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or LUCY?
The Cooper Companies quarterly revenues are $1B, which are larger than Innovative Eyewear quarterly revenues of $253.6K. The Cooper Companies's net income of $117.5M is higher than Innovative Eyewear's net income of -$1.7M. Notably, The Cooper Companies's price-to-earnings ratio is 47.35x while Innovative Eyewear's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.75x versus 3.27x for Innovative Eyewear. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.75x 47.35x $1B $117.5M LUCYInnovative Eyewear3.27x -- $253.6K -$1.7M
-
Which has Higher Returns COO or NXGL?
NexGel has a net margin of 11.54% compared to The Cooper Companies's net margin of -23.57%. The Cooper Companies's return on equity of 5.02% beat NexGel's return on equity of -67.5%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B NXGLNexGel43.61% -$0.11 $6M -
What do Analysts Say About COO or NXGL?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 21.3%. On the other hand NexGel has an analysts' consensus of -- which suggests that it could grow by 27.66%. Given that NexGel has higher upside potential than The Cooper Companies, analysts believe NexGel is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 NXGLNexGel0 0 0 -
Is COO or NXGL More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison NexGel has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or NXGL?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. NexGel pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or NXGL?
The Cooper Companies quarterly revenues are $1B, which are larger than NexGel quarterly revenues of $2.9M. The Cooper Companies's net income of $117.5M is higher than NexGel's net income of -$693K. Notably, The Cooper Companies's price-to-earnings ratio is 47.35x while NexGel's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.75x versus 4.28x for NexGel. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.75x 47.35x $1B $117.5M NXGLNexGel4.28x -- $2.9M -$693K
-
Which has Higher Returns COO or STAA?
Staar Surgical has a net margin of 11.54% compared to The Cooper Companies's net margin of 11.27%. The Cooper Companies's return on equity of 5.02% beat Staar Surgical's return on equity of 5.46%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B STAAStaar Surgical77.31% $0.20 $428.1M -
What do Analysts Say About COO or STAA?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 21.3%. On the other hand Staar Surgical has an analysts' consensus of $41.89 which suggests that it could grow by 73.01%. Given that Staar Surgical has higher upside potential than The Cooper Companies, analysts believe Staar Surgical is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 STAAStaar Surgical7 5 1 -
Is COO or STAA More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Staar Surgical has a beta of 0.587, suggesting its less volatile than the S&P 500 by 41.304%.
-
Which is a Better Dividend Stock COO or STAA?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Staar Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Staar Surgical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or STAA?
The Cooper Companies quarterly revenues are $1B, which are larger than Staar Surgical quarterly revenues of $88.6M. The Cooper Companies's net income of $117.5M is higher than Staar Surgical's net income of $10M. Notably, The Cooper Companies's price-to-earnings ratio is 47.35x while Staar Surgical's PE ratio is 55.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.75x versus 3.51x for Staar Surgical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.75x 47.35x $1B $117.5M STAAStaar Surgical3.51x 55.02x $88.6M $10M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
